Blood biomarkers of kidney transplant rejection, an endless search? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Expert Review of Molecular Diagnostics Year : 2017

Blood biomarkers of kidney transplant rejection, an endless search?


The tailoring of immunosuppressive treatment is recognized as a promising strategy to improve long-term kidney graft outcome. To guide the standard care of transplant recipients, physicians need objective biomarkers that can identify an ongoing pathology with the graft or low intensity signals that will be later evolved to accelerated transplant rejection. The early identification of 'high-risk /low-risk' patients enables the adjustment of standard of caring, including managing the frequency of clinical visits and the immunosuppression dosing. Given their ease of availability and the compatibility with a large technical array, blood-based biomarkers have been widely scrutinized for use as potential predictive and diagnostic biomarkers. Areas covered: Here, the authors report on non-invasive biomarkers, such as modification of immune cell subsets and mRNA and miRNA profiles, identified in the blood of kidney transplant recipients collected before or after transplantation. Expert commentary: Combined with functional tests, the identification of biomarkers will improve our understanding of pathological processes and will contribute to a global improvement in clinical management.
No file

Dates and versions

inserm-02155438 , version 1 (13-06-2019)



Lola Jacquemont, Jean-Paul Soulillou, Nicolas Degauque. Blood biomarkers of kidney transplant rejection, an endless search?. Expert Review of Molecular Diagnostics, 2017, 17 (7), pp.687-697. ⟨10.1080/14737159.2017.1337512⟩. ⟨inserm-02155438⟩
30 View
0 Download



Gmail Facebook X LinkedIn More